J. R. Riordan, J. M. Rommens, B. Kerem, N. Alon, R. Rozmahel et al., Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science, vol.245, issue.4925, pp.1066-73, 1989.

R. C. Boucher, An overview of the pathogenesis of cystic fibrosis lung disease, Adv Drug Deliv Rev, vol.54, pp.1359-71, 2002.

D. G. Downey, S. C. Bell, and J. S. Elborn, Neutrophils in cystic fibrosis, Thorax, vol.64, pp.81-89, 2009.

B. Dhooghe, S. Noel, F. Huaux, and T. Leal, Lung inflammation in cystic fibrosis: pathogenesis and novel therapies, Clin Biochem, vol.47, pp.539-585, 2014.

O. Tabary, J. M. Zahm, J. Hinnrasky, J. P. Couetil, P. Cornillet et al., Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro, Am J Pathol, vol.153, issue.10, pp.65633-65640, 1998.

T. S. Cohen and A. Prince, Cystic fibrosis: a mucosal immunodeficiency syndrome, Nat Med, vol.18, pp.509-528, 2012.

P. Gasse, C. Mary, I. Guenon, N. Noulin, S. Charron et al., IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice, J Clin Invest, vol.117, pp.3786-99, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00316819

J. Palomo, T. Marchiol, J. Piotet, L. Fauconnier, M. Robinet et al., Role of IL-1beta in experimental cystic fibrosis upon P. aeruginosa infection, PLoS ONE, vol.9, p.114884, 2014.

H. Schreuder, C. Tardif, S. Trump-kallmeyer, A. Soffientini, E. Sarubbi et al., A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist, Nature, vol.386, pp.194-200, 1997.

A. Weber, P. Wasiliew, and M. Kracht, Interleukin-1beta (IL-1beta) processing pathway, Sci Signal, vol.3, p.2, 2010.

S. Rao, V. Sigl, R. A. Wimmer, M. Novatchkova, A. Jais et al., RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer, Genes Dev, vol.31, pp.2099-112, 2017.

H. Corvol, N. Rousselet, K. E. Thompson, L. Berdah, G. Cottin et al., FAM13A is a modifier gene of cystic fibrosis lung phenotype regulating rhoa activity, actin cytoskeleton dynamics and epithelial-mesenchymal transition, J Cyst Fibros, vol.17, pp.190-203, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01788583

W. Filipowicz, S. N. Bhattacharyya, and N. Sonenberg, Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight?, Nat Rev Genet, vol.9, pp.102-116, 2008.

R. C. Friedman, K. K. Farh, C. B. Burge, and D. P. Bartel, Most mammalian mRNAs are conserved targets of microRNAs, Genome Res, vol.19, pp.92-105, 2009.

L. Kabir, F. Ambalavanan, N. Liu, G. Li, P. Solomon et al., microRNA-145 antagonism reverses TGF-beta inhibition of F508del CFTR correction in airway epithelia, Am J Respir Crit Care Med, vol.197, pp.632-675, 2017.

S. Bartoszewska, W. Kamysz, B. Jakiela, M. Sanak, J. Kroliczewski et al., miR-200b downregulates CFTR during hypoxia in human lung epithelial cells, Cell Mol Biol Lett, vol.22, p.23, 2017.

P. Bardin, F. Sonneville, H. Corvol, and O. Tabary, Emerging microRNA therapeutic approaches for cystic fibrosis, Front Pharmacol, vol.9, p.1113, 2018.

P. Bardin, E. Marchal-duval, F. Sonneville, S. Blouquit-laye, N. Rousselet et al., Small RNA and transcriptome sequencing reveal the role of miR-199a-3p in inflammatory processes in cystic fibrosis airways, J Pathol, vol.245, pp.410-430, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02390385

L. Wiszniewski, L. Jornot, T. Dudez, A. Pagano, T. Rochat et al., Long-term cultures of polarized airway epithelial cells from patients with cystic fibrosis, Am J Respir Cell Mol Biol, vol.34, pp.39-48, 2006.

P. Chomczynski and N. Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem, vol.162, pp.156-165, 1987.

B. Erdogan, C. Facey, J. Qualtieri, J. Tedesco, E. Rinker et al., Diagnostic microRNAs in myelodysplastic syndrome, Exp Hematol, vol.39, pp.915-941, 2011.

M. A. Tessel, A. L. Benham, N. L. Krett, S. T. Rosen, and P. H. Gunaratne, Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma, Horm Cancer, vol.2, pp.182-191, 2011.

P. Garmilla-ezquerra, C. Sanudo, J. Delgado-calle, M. I. Perez-nunez, M. Sumillera et al., Analysis of the bone microRNome in osteoporotic fractures, Calcif Tissue Int, vol.96, pp.30-37, 2015.

J. Shi, H. Liu, H. Wang, and X. Kong, MicroRNA expression signature in degenerative aortic stenosis, Biomed Res Int, p.4682172, 2016.

S. D. Miyamoto, A. Karimpour-fard, V. Peterson, S. R. Auerbach, K. R. Stenmark et al., Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy, J Heart Lung Transplant, vol.34, pp.724-757, 2015.

M. L. Slattery, J. S. Herrick, L. E. Mullany, E. Wolff, M. D. Hoffman et al., Colorectal tumor molecular phenotype and miRNA: expression profiles and prognosis, Mod Pathol, vol.29, pp.915-942, 2016.

W. Yan, W. Yang, Z. Liu, and G. Wu, Characterization of microRNA expression in primary human colon adenocarcinoma cells (SW480) and their lymph node metastatic derivatives (SW620), Onco Targets Ther, vol.11, pp.4701-4710, 2018.

C. L. Chen, C. H. Lin, A. L. Li, C. C. Huang, B. Y. Shen et al., Plasma miRNA profile is a biomarker associated with urothelial carcinoma in chronic hemodialysis patients, Am J Physiol Renal Physiol, vol.316, pp.1094-102, 2019.

L. P. Wang, Y. Z. Gao, B. Song, G. Yu, H. Chen et al., MicroRNAs in the progress of diabetic nephropathy: a systematic review and meta-analysis. Evid Based, Complement Alternat Med, p.3513179, 2019.

J. Encarnacion-medina, C. Ortiz, R. Vergne, L. Padilla, and J. Matta, MicroRNA expression changes in women with breast cancer stratified by DNA repair capacity levels, J Oncol, p.7820275, 2019.

O. Tabary, S. Escotte, J. P. Couetil, D. Hubert, D. Dusser et al., Genistein inhibits constitutive and inducible NFkappaB activation and decreases IL-8 production by human cystic fibrosis bronchial gland cells, Am J Pathol, vol.155, issue.10, pp.65143-65150, 1999.

J. Y. Jang, Y. S. Lee, Y. K. Jeon, K. Lee, J. J. Jang et al., ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma, Exp Mol Med, vol.45, p.3, 2013.

S. H. Baik, J. Lee, Y. S. Lee, J. Y. Jang, and C. W. Kim, ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells, Exp Mol Med, vol.48, p.222, 2016.

T. He, R. Sun, Y. Li, and Z. S. Katusic, Effects of brain-derived neurotrophic factor on MicroRNA expression profile in human endothelial progenitor cells, Cell Transplant, vol.27, pp.1005-1014, 2018.

A. Morishita, H. Yoneyama, H. Iwama, K. Fujita, M. Watanabe et al., Circulating microRNA-636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavir, Oncotarget, vol.9, pp.32054-62, 2018.

M. Garcia-lacarte, J. A. Martinez, M. A. Zulet, and F. I. Milagro, Implication of miR-612 and miR-1976 in the regulation of TP53 and CD40 and their relationship in the response to specific weight-loss diets, PLoS ONE, vol.13, p.201217, 2018.

E. Fabbri, M. Borgatti, G. Montagner, N. Bianchi, A. Finotti et al., Expression of miR-93 and IL-8 during pseudomonas aeruginosa mediated induction of pro-inflammatory responses, Am J Respir Cell Mol Biol, vol.50, pp.1144-55, 2014.

I. K. Oglesby, S. F. Vencken, R. Agrawal, K. Gaughan, K. Molloy et al., miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production, Eur Respir J, vol.46, pp.1350-60, 2015.

H. J. Zhou, L. Q. Wang, Q. S. Xu, Z. X. Fan, Y. Zhu et al., Downregulation of miR-199b promotes the acute spinal cord injury through IKKbeta-NF-kappaB signaling pathway activating microglial cells, Exp Cell Res, vol.349, pp.60-67, 2016.

M. Dabbah, O. Attar-schneider, V. Zismanov, T. Matalon, S. Lishner et al., Letter to the Editor: miR-199b-3p and miR-199a-3p are isoforms with identical sequence and established function as tumor and metastasis suppressors, J Leukoc Biol, vol.101, p.1069, 2017.

G. T. Brown, P. Narayanan, W. Li, R. L. Silverstein, and T. M. Mcintyre, Lipopolysaccharide stimulates platelets through an IL-1beta autocrine loop, J Immunol, vol.191, pp.5196-203, 2013.

D. Pal, S. Dasgupta, R. Kundu, S. Maitra, G. Das et al., Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance, Nat Med, vol.18, pp.1279-85, 2012.

Y. Liu, T. Li, Y. Xu, E. Xu, M. Zhou et al., Effects of TLR4 gene silencing on the proliferation and apotosis of hepatocarcinoma HEPG2 cells, Oncol Lett, vol.11, pp.3054-60, 2016.

A. F. Petit-bertron, O. Tabary, H. Corvol, J. Jacquot, A. Cment et al., Circulating and airway neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10, Cytokine, vol.41, pp.54-60, 2008.

V. Iori, A. M. Iyer, T. Ravizza, L. Beltrame, L. Paracchini et al., Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy, Neurobiol Dis, vol.99, pp.12-23, 2017.

G. Bonizzi and M. Karin, The two NF-kappaB activation pathways and their role in innate and adaptive immunity, Trends Immunol, vol.25, pp.280-288, 2004.

E. Dimango, A. J. Ratner, R. Bryan, S. Tabibi, and A. Prince, Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells, J Clin Invest, vol.101, pp.2598-605, 1998.

C. Verhaeghe, C. Remouchamps, B. Hennuy, A. Vanderplasschen, A. Chariot et al., Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways, Biochem Pharmacol, vol.73, pp.1982-94, 2007.

F. Bazzoni, M. Rossato, M. Fabbri, D. Gaudiosi, M. Mirolo et al., Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals, Proc Natl Acad Sci, vol.106, pp.5282-5289, 2009.

S. Vasudevan, Y. Tong, and J. A. Steitz, Switching from repression to activation: microRNAs can up-regulate translation, Science, vol.318, pp.1931-1935, 2007.

Y. Y. Kong, H. Yoshida, I. Sarosi, H. L. Tan, E. Timms et al., OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis, Nature, vol.397, pp.315-338, 1999.

F. Velard, M. Delion, F. Lemaire, O. Tabary, C. Guillaume et al., Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy? Eur Respir, vol.45, pp.845-848, 2015.

K. A. Knoop, N. Kumar, B. R. Butler, S. K. Sakthivel, R. T. Taylor et al., RANKL is necessary and sufficient to initiate development of antigensampling M cells in the intestinal epithelium, J Immunol, vol.183, pp.5738-5785, 2009.

S. W. Rossi, M. Y. Kim, A. Leibbrandt, S. M. Parnell, W. E. Jenkinson et al., RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla, J Exp Med, vol.204, pp.41-50, 2000.

P. Secchiero, F. Corallini, E. Barbarotto, E. Melloni, M. G. Di-iasio et al., Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells, J Cell Physiol, vol.207, pp.158-64, 2006.

P. Furio-tari, S. Tarazona, T. Gabaldon, A. J. Enright, and A. Conesa, spongeScan: a web for detecting microRNA binding elements in lncRNA sequences, Nucleic Acids Res, vol.44, pp.176-80, 2016.

N. A. Schultz, C. Dehlendorff, B. V. Jensen, J. K. Bjerregaard, K. R. Nielsen et al., MicroRNA biomarkers in whole blood for detection of pancreatic cancer, JAMA, vol.311, pp.392-404, 2014.

S. Eissa, M. Matboli, R. Aboushahba, M. M. Bekhet, and Y. Soliman, Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease, J Diabetes Complications, vol.30, pp.1585-92, 2016.

E. Pashaei, E. Pashaei, M. Ahmady, M. Ozen, and N. Aydin, Metaanalysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy, PLoS ONE, vol.12, p.179543, 2017.

N. L. Cook, T. N. Pereira, P. J. Lewindon, R. W. Shepherd, and G. A. Ramm, Circulating microRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis, J Pediatr Gastroenterol Nutr, vol.60, pp.247-54, 2015.

Y. Huang, S. Zhang, X. Fang, L. Qin, Y. Fan et al., Plasma miR-199a-5p is increased in neutrophilic phenotype asthma patients and negatively correlated with pulmonary function, PLoS ONE, vol.13, p.193502, 2018.